• 1. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 2. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 3. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 4. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

Introduction to Ethyl 3-methylpyrrolidine-3-carboxylate Hydrochloride (CAS No. 1421604-12-7)

Ethyl 3-methylpyrrolidine-3-carboxylate hydrochloride (CAS No. 1421604-12-7) is a significant compound in the field of pharmaceutical chemistry, known for its versatile applications in drug development and synthetic organic chemistry. This compound, characterized by its hydrochloride salt form, has garnered attention due to its structural properties and potential biological activities. The ethyl moiety and the 3-methylpyrrolidine core contribute to its unique chemical profile, making it a valuable intermediate in the synthesis of more complex molecules.

The chemical structure of ethyl 3-methylpyrrolidine-3-carboxylate hydrochloride consists of a pyrrolidine ring substituted with a methyl group at the 3-position and an ester group at the 1-position, which is further modified by a hydrochloride salt. This configuration imparts specific reactivity and stability, making it suitable for various chemical transformations. The compound's solubility profile and thermal stability are also critical factors that influence its utility in pharmaceutical formulations.

In recent years, ethyl 3-methylpyrrolidine-3-carboxylate hydrochloride has been extensively studied for its potential applications in medicinal chemistry. One of the most promising areas is its role as a building block in the synthesis of bioactive molecules. Researchers have explored its use in creating novel compounds with therapeutic effects, particularly in the treatment of neurological disorders and infectious diseases. The pyrrolidine scaffold is known for its presence in many pharmacologically active agents, and modifications to this core structure can lead to compounds with enhanced efficacy and reduced side effects.

A notable study published in the Journal of Medicinal Chemistry highlighted the synthesis of several derivatives of ethyl 3-methylpyrrolidine-3-carboxylate hydrochloride, demonstrating their potential as inhibitors of enzymes involved in pathogenic processes. The study emphasized the importance of optimizing the ester and methyl substituents to achieve desired pharmacokinetic properties. This research underscores the compound's significance as a precursor in drug discovery efforts.

The synthetic pathways for ethyl 3-methylpyrrolidine-3-carboxylate hydrochloride have also been refined to improve yield and purity. Advances in catalytic methods and green chemistry principles have enabled more efficient production processes. For instance, transition metal-catalyzed reactions have been employed to streamline the formation of the pyrrolidine ring, reducing waste and energy consumption. These innovations align with global efforts to promote sustainable pharmaceutical manufacturing.

Another area where ethyl 3-methylpyrrolidine-3-carboxylate hydrochloride has shown promise is in the development of chiral compounds. The presence of stereocenters in its structure allows for the synthesis of enantiomerically pure derivatives, which are often required for optimal biological activity. Techniques such as asymmetric hydrogenation and chiral resolution have been applied to produce these enantiomers with high precision. This capability is crucial for developing drugs that interact selectively with biological targets.

The compound's stability under various conditions has also been a focus of research. Studies have investigated its behavior under different pH levels, temperatures, and storage conditions to ensure consistent quality in pharmaceutical products. Stability data is essential for regulatory approval and commercialization, as it directly impacts shelf life and patient safety.

In conclusion, ethyl 3-methylpyrrolidine-3-carboxylate hydrochloride (CAS No. 1421604-12-7) is a multifaceted compound with significant potential in pharmaceutical research and development. Its unique structural features make it a valuable intermediate for synthesizing bioactive molecules, particularly those targeting neurological and infectious diseases. Ongoing research continues to uncover new applications and improve synthetic methodologies, reinforcing its importance in modern drug discovery.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)